Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks. by David T Arnold, Charmaine Donald, Max Lyon, Fergus W Hamilton, Anna J Morley, Marie Attwood, Alexandra Dipper, Shaney L Barratt

Get full text

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre... by Anna C. Bibby, Duneesha De Fonseka, Anna J. Morley, Emma Keenan, Alfredo Addeo, Sarah Smith, Anthony J. Edey, Nick A. Maskell

Get full text

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma by Duneesha De Fonseka, David T. Arnold, Anna J. Morley, Mary Brett, Nidhi Bhatt, Anthony Edey, Richard Daly, Anna C. Bibby, Nick A. Maskell

Get full text

Pleural fluid adenosine deaminase (pfADA) in the diagnosis of tuberculous effusions in a low incidence population. by David T Arnold, Rahul Bhatnagar, Lynette D Fairbanks, Natalie Zahan-Evans, Amelia O Clive, Anna J Morley, Andrew R L Medford, Nicholas A Maskell

Get full text

A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study. by Amelia O Clive, Clare E Hooper, Anthony J Edey, Anna J Morley, Natalie Zahan-Evans, David Hall, Iain Lyburn, Paul White, Jeremy P Braybrooke, Iara Sequeiros, Stephen M Lyen, Tim Milton, Brennan C Kahan, Nick A Maskell

Get full text